Author:
Xu Jiqin,Wang Hongyun,Wang Huiyan,Chen Qing,Zhang Li,Song Chao,Zhou Qianqian,Hong Ying
Funder
Nanjing Medical Technology Development Project
National Health and Family Planning Commission, Science and Education Department “Research on cervical cancer screening technology and demonstration for Chinese rural areas”
Publisher
Springer Science and Business Media LLC
Subject
Genetics,General Medicine
Reference39 articles.
1. Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet Suppl. 2018;2:22–36.
2. Pimple S, Mishra G, Shastri S. Global strategies for cervical cancer prevention. Curr Opin Obstet Gynecol. 2016;28:4–10.
3. Tsikouras P, Zervoudis S, Manav B, Tomara E, Iatrakis G, Romanidis C, Bothou A, Galazios G. Cervical cancer: screening, diagnosis and staging. J BUON. 2016;21:320–5.
4. Jiang W, Pan JJ, Deng YH, Liang MR, Yao LH. Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer. J Gynecol Oncol. 2017;28:e75.
5. Goodman A. HPV testing as a screen for cervical cancer. BMJ. 2015;350:h2372.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献